<p>Kaplan–Meier estimates of overall survival by <i>SULF2</i> methylation status and clinical characteristics.</p
Kaplan–Meier estimates of overall survival in patients with and without sarcopenia.</p
A) survival estimates of subjects carrying (Met+) or not carrying (Met-) the Met allele of the rs626...
<p>Kaplan-Meier analysis of overall survival in 58 cancer patients stratified by the cytological dia...
<p>Kaplan-Meier survival estimates of overall survival for methylation levels in peripheral blood of...
<div><p>Kaplan-Meier estimation of overall survival (<b>A</b>) and metastasis-free survival (<b>B</b...
<p>Patients with <i>RASSF1A</i> promoter methylation showed poorer over-all survival (A) (<i>P</i> <...
<p><i>CXCR4</i> methylation status and the correlation with (A) overall survival (OS) and (B) diseas...
<p>Kaplan-Meier survival analysis of overall survival of 526 HNSCC patients stratified according to ...
<p>Overall survival was compared according to methylation status of <i>HS3ST2</i> in 193 node-negati...
<p>The full black (resp. green) line corresponds to the survival for samples classified as TR (resp....
<p>181 patients from the HumanMethylation27 BeadChip Cohort had the appropriate clinical data.</p
<p>145 patients from the HumanMethylation450 BeadChip Cohort had the appropriate clinical data.</p
<p>The curves show CF-free survival of patients from the low (LM, <15% <i>GSTP1</i> methylation), mo...
<p>Patients with concurrent promoter methylation and LOH of <i>RASSF1A</i> showed the poorest over-a...
<p>Kaplan-Meier survival curves of patients with different stage associated with to Sox2 mRNA level ...
Kaplan–Meier estimates of overall survival in patients with and without sarcopenia.</p
A) survival estimates of subjects carrying (Met+) or not carrying (Met-) the Met allele of the rs626...
<p>Kaplan-Meier analysis of overall survival in 58 cancer patients stratified by the cytological dia...
<p>Kaplan-Meier survival estimates of overall survival for methylation levels in peripheral blood of...
<div><p>Kaplan-Meier estimation of overall survival (<b>A</b>) and metastasis-free survival (<b>B</b...
<p>Patients with <i>RASSF1A</i> promoter methylation showed poorer over-all survival (A) (<i>P</i> <...
<p><i>CXCR4</i> methylation status and the correlation with (A) overall survival (OS) and (B) diseas...
<p>Kaplan-Meier survival analysis of overall survival of 526 HNSCC patients stratified according to ...
<p>Overall survival was compared according to methylation status of <i>HS3ST2</i> in 193 node-negati...
<p>The full black (resp. green) line corresponds to the survival for samples classified as TR (resp....
<p>181 patients from the HumanMethylation27 BeadChip Cohort had the appropriate clinical data.</p
<p>145 patients from the HumanMethylation450 BeadChip Cohort had the appropriate clinical data.</p
<p>The curves show CF-free survival of patients from the low (LM, <15% <i>GSTP1</i> methylation), mo...
<p>Patients with concurrent promoter methylation and LOH of <i>RASSF1A</i> showed the poorest over-a...
<p>Kaplan-Meier survival curves of patients with different stage associated with to Sox2 mRNA level ...
Kaplan–Meier estimates of overall survival in patients with and without sarcopenia.</p
A) survival estimates of subjects carrying (Met+) or not carrying (Met-) the Met allele of the rs626...
<p>Kaplan-Meier analysis of overall survival in 58 cancer patients stratified by the cytological dia...